loading
Schlusskurs vom Vortag:
$15.50
Offen:
$15.34
24-Stunden-Volumen:
36,820
Relative Volume:
0.22
Marktkapitalisierung:
$592.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.25%
1M Leistung:
+29.77%
6M Leistung:
+15.58%
1J Leistung:
-20.59%
1-Tages-Spanne:
Value
$15.20
$16.23
1-Wochen-Bereich:
Value
$14.10
$16.23
52-Wochen-Spanne:
Value
$7.13
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Firmenname
Rapport Therapeutics Inc
Name
Telefon
857-321-8020
Name
Adresse
1325 BOYLSTON STREET, BOSTON
Name
Mitarbeiter
69
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
RAPP's Discussions on Twitter

Vergleichen Sie RAPP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RAPP
Rapport Therapeutics Inc
16.23 554.76M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.69 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
570.82 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.14 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
588.61 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.96 31.99B 3.81B -644.79M -669.77M -6.24

Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-08 Eingeleitet Citizens JMP Mkt Outperform
2024-07-02 Eingeleitet Jefferies Buy
2024-07-02 Eingeleitet Stifel Buy
2024-07-02 Eingeleitet TD Cowen Buy

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

pulisher
Jul 23, 2025

What drives Rapport Therapeutics Inc. stock priceTremendous return rates - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Rapport Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Rapport Therapeutics Inc. stockHigh-impact stock picks - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Rapport Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 18, 2025

What drives EOSEW stock priceExceptional gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Top Dividend Stocks in India Expert Trader GroupRapid wealth multiplication - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Palvella Therapeutics Inc. stockAccelerated capital growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Eaton Vance Municipal Income 2028 Term Trust stock outlookSecure Growth Trading Plan - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

why rapport therapeutics inc. stock attracts strong analyst attentionFree Exclusive Access to Stock Gurus - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

JMP reiterates Market Outperform rating on Rapport Therapeutics stock By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Why Rapport Therapeutics Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

What makes PTC Therapeutics Inc. stock price move sharplyTop Momentum Stock Pick - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Rapport Therapeutics Reports Q1 2025 Financial Results - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Why CRMD stock attracts strong analyst attentionAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How High Can MOON(moon coin) GoFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Rapport Therapeutics Inc. stock performs during market volatilitySmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Entegris Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Coya Therapeutics Inc. stock attracts strong analyst attentionFree Access to Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes CIGI stock price move sharplyHigh Return Intraday Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Rapport Therapeutics Inc. stock price move sharplyFree Insider Trading Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How American Water Works Company Inc. stock performs during market volatilityChart Breakout Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes IPCXU stock price move sharplyFree Group Entry - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

When CLEU stock expected to show significant growthIs SXTC stock a good long term investment optionTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why SPHL stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Leverage AI to enhance your marketing strategy with real time consumer insightsHigh Return Setup Scanner - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest

Jul 14, 2025
pulisher
Jul 11, 2025

Rapport Therapeutics’ (RAPP) Market Outperform Rating Reiterated at JMP Securities - Defense World

Jul 11, 2025
pulisher
Jul 08, 2025

How will RAPP's Q1 2025 earnings forecast impact investors? - AInvest

Jul 08, 2025
pulisher
Jun 30, 2025

Rapport Therapeutics, Inc.(NasdaqGM: RAPP) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Bredt David
Chief Scientific Officer
Jun 16 '25
Sale
11.00
8,500
93,522
443,642
$23.62
price up icon 3.28%
$36.59
price up icon 1.62%
$103.43
price up icon 0.09%
$27.66
price down icon 1.21%
$113.95
price down icon 0.57%
biotechnology ONC
$296.05
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):